New asthma inhaler shows promise in early trial
NCT ID NCT06795906
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 29 times
Summary
This early-stage study tested a new inhaled medicine called AZD8630 in 24 adults with asthma who already use medium-to-high dose steroid inhalers plus long-acting bronchodilators. Participants took the drug once daily for 2 weeks to check for side effects, how the body processes it, and any changes in asthma inflammation markers. The goal was to see if it is safe and worth testing further.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Ahrensburg, 22926, Germany
-
Research Site
Berlin, 10119, Germany
-
Research Site
Mainz, 55128, Germany
Conditions
Explore the condition pages connected to this study.